Heyman Tomas J.
Insider CIK 1814673 · OPTN Director · AKRO Director · LEGN Director · ADGI Director · XLO Director · EXEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech Corp | A Award | 2026-09-24 | 2026-09-28 | 20,986 | — | $0 | 53,720 | SEC↗ |
| LEGN Legend Biotech Corp | A Award | 2026-09-24 | 2026-09-28 | 20,986 | — | $0 | 53,720 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2026-05-27 | 2026-05-29 | 8,367 | — | $0 | 50,649 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 13,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 15,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 26,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 9,398 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-03 | 2025-06-05 | 9,398 | — | $0 | 9,398 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2025-05-29 | 2025-05-30 | 9,812 | — | $0 | 42,282 | SEC↗ |
| OPTN OptiNose, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-21 | 2,133 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-21 | 3,566 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-21 | 962 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-21 | 1,925 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-21 | 5,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2025-05-21 | 2025-05-22 | 4,544 | $44.29 | $201.3K | 32,470 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-06-08 | 2024-06-11 | 26,000 | — | $0 | 26,000 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 75,000 | — | $0 | 75,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2024-05-31 | 2024-06-04 | 18,838 | — | $0 | 37,014 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-06-23 | 2023-06-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-06-16 | 2023-06-21 | 26,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-06-16 | 2023-06-21 | 26,000 | $25.04 | $651.0K | 26,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-16 | 2023-06-21 | 26,000 | $54.67 | $1.42M | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2023-06-12 | 2023-06-13 | 13,200 | — | $0 | 13,200 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 53,500 | — | $0 | 53,500 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2023-05-31 | 2023-06-02 | 36,353 | — | $0 | 36,353 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2023-05-31 | 2023-06-02 | 18,176 | — | $0 | 18,176 | SEC↗ |
| IVVD Invivyd, Inc. | A Award deriv | 2023-05-23 | 2023-05-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2022-09-15 | 2022-09-16 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 32,000 | — | $0 | 32,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2021-06-09 | 2021-06-10 | 14,439 | — | $0 | 14,439 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 13,000 | — | $0 | 13,000 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2020-12-01 | 2020-12-04 | 28,879 | — | $0 | 28,879 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 26,000 | — | $0 | 26,000 | SEC↗ |